ES2034484T3 - El uso de oxidos de tiadiazol para la preparacion de una composicion farmaceutica para el tratamiento de desordenes de motilidad gastrointestinal. - Google Patents

El uso de oxidos de tiadiazol para la preparacion de una composicion farmaceutica para el tratamiento de desordenes de motilidad gastrointestinal.

Info

Publication number
ES2034484T3
ES2034484T3 ES198989108509T ES89108509T ES2034484T3 ES 2034484 T3 ES2034484 T3 ES 2034484T3 ES 198989108509 T ES198989108509 T ES 198989108509T ES 89108509 T ES89108509 T ES 89108509T ES 2034484 T3 ES2034484 T3 ES 2034484T3
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
tiadiazole
disorders
oxides
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989108509T
Other languages
English (en)
Inventor
Jaswant S. Gidda
Ivo Monkovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2034484T3 publication Critical patent/ES2034484T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE AL USO DE CIERTOS COMPUESTOS DE OXIDO DE TIADIAZOL PARA PREPARAR UNA COMPOSICION FARMACEUTICA PARA TRATAR DESORDENES DE MOTILIDAD GASTROINTESTINAL.
ES198989108509T 1988-05-12 1989-05-11 El uso de oxidos de tiadiazol para la preparacion de una composicion farmaceutica para el tratamiento de desordenes de motilidad gastrointestinal. Expired - Lifetime ES2034484T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/193,025 US4829073A (en) 1988-05-12 1988-05-12 Thiadiazole oxides for treating gastrointestinal motility disorders

Publications (1)

Publication Number Publication Date
ES2034484T3 true ES2034484T3 (es) 1993-04-01

Family

ID=22711984

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989108509T Expired - Lifetime ES2034484T3 (es) 1988-05-12 1989-05-11 El uso de oxidos de tiadiazol para la preparacion de una composicion farmaceutica para el tratamiento de desordenes de motilidad gastrointestinal.

Country Status (7)

Country Link
US (1) US4829073A (es)
EP (1) EP0341722B1 (es)
JP (1) JPH01313424A (es)
AT (1) ATE79753T1 (es)
DE (1) DE68902576T2 (es)
ES (1) ES2034484T3 (es)
GR (1) GR3005563T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK60493D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
AU699008B2 (en) * 1995-05-18 1998-11-19 Zeria Pharmaceutical Co., Ltd. Aminothiazole derivative, medicament containing the same, and intermediate for preperation of said compound
JP4153043B2 (ja) * 1996-10-24 2008-09-17 ゼリア新薬工業株式会社 置換ベンゾイルアミノチアゾール誘導体及びそれを含有する医薬
TWI256314B (en) * 2000-02-09 2006-06-11 Mitsubishi Pharma Corp Preventive-therapeutical medicament for gastroesophageal reflux disease
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
US4471122A (en) * 1981-03-03 1984-09-11 Bristol-Myers Company Thiadiazole histamine H2 -antagonists
US4567191A (en) * 1983-06-07 1986-01-28 Merck & Co., Inc. Amino-phenyl-thiadiazoledioxides as gastric secretion inhibitors

Also Published As

Publication number Publication date
DE68902576T2 (de) 1993-01-21
JPH0480004B2 (es) 1992-12-17
US4829073A (en) 1989-05-09
EP0341722A2 (en) 1989-11-15
ATE79753T1 (de) 1992-09-15
DE68902576D1 (de) 1992-10-01
EP0341722B1 (en) 1992-08-26
JPH01313424A (ja) 1989-12-18
EP0341722A3 (en) 1990-10-10
GR3005563T3 (es) 1993-06-07

Similar Documents

Publication Publication Date Title
PH25508A (en) Substituted quinazoline derivatives for use in gastrointestinal diseases
GR1002332B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
RU93058555A (ru) Производные хинуклидина, способ их получения, фармацевтическая композиция, способ лечения или профилактики
DE60140285D1 (de) Verwendung von Wachstumshormonsekretagoga zur Förderung der Beweglichkeit des Verdauungstrakts
DK275488D0 (da) Indolonderivater
RU2003118411A (ru) Кристаллические производные 1-метилкарбапенема
DE69327328D1 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
FI923663A0 (fi) Terapeutiska foereningar.
IL150817A0 (en) Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
ES511208A0 (es) Procedimiento para la obtencion de una preparacion galenica antagonista al calcio.
ES2034484T3 (es) El uso de oxidos de tiadiazol para la preparacion de una composicion farmaceutica para el tratamiento de desordenes de motilidad gastrointestinal.
DK0624569T3 (da) MMDA-antagonister
PT86859A (pt) Process for the preparation of 9-ethyl-6,9-di-hydro-4,6-dioxo-10-propyl-4h-pyrano]3,2-g"-quinoline-2,8-calcium dicarboxilate and of pharmaceutical compounds containing it
KR910015300A (ko) 부스피론 : 수면 무호흡증의 치료용도
RU95110110A (ru) Производные бензофурана, способ их получения, фармкомпозиция и способ лечения
ES557391A0 (es) Un procedimiento para la preparacion de espiro(imidazolidin-4,4'-(3'h)quinolinas)
IE780217L (en) 1,3,5-triazine-2,6-dione derivatives
DK526087A (da) Antikonvulsive aminosyrederivater
DK0497978T3 (da) Cephalosporinforbindelser og fremstilling heraf.
EP0301466A3 (en) Uricosuric composition
RU94013118A (ru) Гетероциклические соединения и содержащие их фармацевтические соединения
KR930019626A (ko) 신규의 아세트아미드 유도체 및 그 용도
RU93047670A (ru) Соединения общей формулы, способы их получения, фармацевтическая композиция и пестициды на их основе
DK681688A (da) Pyrimidonforbindelser og farmaceutisk acceptable salte heraf

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 341722

Country of ref document: ES